Recent advances have shown the effectiveness of sirolimus, an mTOR inhibitor, in infants with severe diffuse CHI that had been unresponsive to medical therapy (10,11,12,13), one of whom had undergone subtotal pancreatectomy (10). Here, MTOR is linked to congenital isolated hyperinsulinism.